These final results, together with a past report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,two assist the strategy of targeting ACKR3 as a novel approach to modulate the opioid program, which could open new therapeutic avenues for opioid-associated disorders. Healthful joints let us to https://pearlc191vsp4.frewwebs.com/profile